Dextroamphetamine, Amphetamine 20mg Tablets

Dextroamphetamine, Amphetamine 20mg Tablets
Dextroamphetamine Saccharate
Amphetamine Aspartate
Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of a Single Entity Amphetamine Product)

Audience: Pharmacists, consumers

[Posted 08/14/2009] Barr Laboratories, Inc. issued a voluntary recall of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of a Single Entity Amphetamine Product) 20mg Tablets, 100 count bottles, lot number 311756. The product is being recalled because the affected lot may contain some tablets exceeding weight requirements which may lead to super-potent tablets.

Clinically significant adverse reactions to a supratherapeutic dose could include cardiovascular, neurologic, psychiatric and gastrointestinal reactions. Customers who have this lot in their possession are instructed to cease using the product and return it to their pharmacy/distributor.

[08/13/2009 - Press Release - Barr Laboratories, Inc.]

abrir aquí para acceder al documento FDA:
Dextroamphetamine, Amphetamine 20mg Tablets